# Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group - IOS Press 5 Sep 24 publications # Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group - IOS Press Aline Delvac Kirsi Kinnunen Koen Van Laere Marina Papoutsi Mitsuko Nakajima Nicola Hobbs Priyantha Herath Rachael Scahill Wim Vandenberghe [ ](https://x.com/intent/tweet?url=https://ixico.com/news-and-resources/publications/neuroimaging-to-facilitate-clinical-trials-in-huntingtons-disease-current-opinion-from-the-ehdn-imaging-working-group-ios-press/) [ ](https://bsky.app/intent/compose?text=https://ixico.com/news-and-resources/publications/neuroimaging-to-facilitate-clinical-trials-in-huntingtons-disease-current-opinion-from-the-ehdn-imaging-working-group-ios-press/) [ ](https://www.facebook.com/sharer/sharer.php?u=https://ixico.com/news-and-resources/publications/neuroimaging-to-facilitate-clinical-trials-in-huntingtons-disease-current-opinion-from-the-ehdn-imaging-working-group-ios-press/) [ ](https://www.linkedin.com/shareArticle?mini=true&url=https://ixico.com/news-and-resources/publications/neuroimaging-to-facilitate-clinical-trials-in-huntingtons-disease-current-opinion-from-the-ehdn-imaging-working-group-ios-press/) [ Download ](/assets/downloads/Neuroimaging-to-Facilitate-Clinical-Trials-in-Huntingtons-Disease-Current-Opinion-from-the-EHDN-Imaging-Working-Group-IOS-Press.pdf) ![Image Neuroimaging to Facilitate Clinical Trials in Huntingtons Disease Current Opinion from the EHDN Imaging Working Group](/assets/blog-images/Image-Neuroimaging-to-Facilitate-Clinical-Trials-in-Huntingtons-Disease-Current-Opinion-from-the-EHDN-Imaging-Working-Group__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp)This comprehensive overview of the roles of structural, functional, and diffusion MRI, PET, MRS, and MEG serves as a resource for effectively integrating neuroimaging methodologies into the design and execution of Huntington's disease clinical trials. The paper discusses their applications in patient selection, safety monitoring, and demonstrating efficacy. It additionally addresses challenges in translation to trial settings, including equipment requirements, standardization, patient burden, and data interpretation. Links to where to access this research article: - [Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group - IOS Press](https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcontent.iospress.com%2Farticles%2Fjournal-of-huntingtons-disease%2Fjhd240016&data=05%7C02%7Cjney.antique%40ixico.com%7C91539bc3c57f4ded9ba108dccdc09590%7Cd5a3b5c97a6b4ab9abee3de97e9d4955%7C0%7C0%7C638611474540847476%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=j9FU6c70rPGhhOWG27dZ1BN70K5hzePiCH0Ur1JpT3c%3D&reserved=0 "Original URL: https://content.iospress.com/articles/journal-of-huntingtons-disease/jhd240016. Click or tap if you trust this link.") [ Back to Scientific Publications ](/news-and-resources/publications/) ### Recents ![Evaluating the Impact of Scanner Harmonisation with ComBat on Longitudinal Brain Volume Measures in Huntington’s Disease](/assets/blog-images/EHDN-2026-Poster__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) 29 Oct 26 publications [Evaluating the Impact of Scanner Harmonisation with ComBat on Longitudinal Brain Volume Measures in Huntington’s Disease](/news-and-resources/publications/new-blog-evaluating-the-impact-of-scanner-harmonisation-with-combat-on-longitudinal-brain-volume-measures-in-huntingtons-disease-post/) [Neuromelanin-Sensitive MRI of the Substantia Nigra: Comparing TSE and MT-GRE Contrast](/news-and-resources/publications/contrast-ratio-assessment-of-the-substantia-nigra-in-neuromelanin-sensitive-mri/) [Improving Neuromelanin-sensitive MRI measurement ](/news-and-resources/publications/improving-neuromelanin-sensitive-mri-measurement/) [Further validation of IXI technology platform automation capabilities](/news-and-resources/publications/further-validation-of-ixi-technology-platform-automation-capabilities/) [Interchangeability of blood-based biomarkers and PET to identify Alzheimer's disease pathology](/news-and-resources/publications/interchangeability-of-blood-based-biomarkers-and-pet-to-identify-alzheimers-disease-pathology/) ### Library [November 2026](/news-and-resources/publications/archive/2026/11/) [October 2026](/news-and-resources/publications/archive/2026/10/) [September 2026](/news-and-resources/publications/archive/2026/09/) [July 2026](/news-and-resources/publications/archive/2026/07/) [June 2026](/news-and-resources/publications/archive/2026/06/) [May 2026](/news-and-resources/publications/archive/2026/05/) [April 2026](/news-and-resources/publications/archive/2026/04/) [March 2026](/news-and-resources/publications/archive/2026/03/) [February 2026](/news-and-resources/publications/archive/2026/02/) [January 2026](/news-and-resources/publications/archive/2026/01/) [2025](/news-and-resources/publications/archive/2025/) [2024](/news-and-resources/publications/archive/2024/) [2023](/news-and-resources/publications/archive/2023/) [2022](/news-and-resources/publications/archive/2022/) [2021](/news-and-resources/publications/archive/2021/) [2020](/news-and-resources/publications/archive/2020/) [2019](/news-and-resources/publications/archive/2019/)